BIOMAT Database Logo BIOMAT Database Logo

Symposium on immunosuppressive drugs. Forward and introduction. 1967

R Schwartz

UI MeSH Term Description Entries
D009316 National Institutes of Health (U.S.) An operating division of the US Department of Health and Human Services. It is concerned with the overall planning, promoting, and administering of programs pertaining to health and medical research. United States National Institutes of Health,National Institutes of Health
D014181 Transplantation Immunology A general term for the complex phenomena involved in allo- and xenograft rejection by a host and graft vs host reaction. Although the reactions involved in transplantation immunology are primarily thymus-dependent phenomena of cellular immunity, humoral factors also play a part in late rejection. Immunology, Transplantation
D014481 United States A country in NORTH AMERICA between CANADA and MEXICO.

Related Publications

R Schwartz
Symposium on immunosuppressive drugs. Forward and introduction.
January 1967, Federation proceedings,
R Schwartz
Symposium on immunosuppressive drugs. Immunosuppressive drugs. I.
January 1967, Federation proceedings,
R Schwartz
Symposium on immunosuppressive drugs. Late effects of immunosuppressive anticancer drugs.
January 1967, Federation proceedings,
R Schwartz
Symposium on drugs. Introduction.
January 1979, Ophthalmology,
R Schwartz
Symposium on immunosuppressive drugs. Summary and concluding remarks.
January 1967, Federation proceedings,
R Schwartz
Symposium on immunosuppressive drugs. Other clinical considerations.
January 1967, Federation proceedings,
R Schwartz
Symposium on drugs in pregnancy: introduction.
November 1981, Obstetrics and gynecology,
R Schwartz
Symposium on immunosuppressive drugs. Biochemistry and pharmacology of purine analogues.
January 1967, Federation proceedings,
R Schwartz
Symposium on therapeutic controversies. Myasthenia gravis. Steroids and immunosuppressive drugs.
January 1978, Transactions of the American Neurological Association,
R Schwartz
Symposium on immunosuppressive drugs. Attributes of clinically used immunosuppressive drugs: possible future uses of antilymphoid sera.
January 1967, Federation proceedings,
Copied contents to your clipboard!